| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |